Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edward Warda
The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Related publications
Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
P1.01-43 Next-Generation Sequencing in the Exploration of Genetic Heterogeneity for Lung Adenocarcinoma Patients With EGFR Activating Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
CT Imaging-Based Histogram Features for Prediction of EGFR Mutation Status of Bone Metastases in Patients With Primary Lung Adenocarcinoma
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients
Oncology Reports
Medicine
Cancer Research
Oncology
EGFR Inhibitors in Treatment of Lung Adenocarcinoma
Research in Oncology
P001 Discrepancy of Oncogenic Mutations in Bone Metastasis Derived From Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Erlotinib in Symptomatic Brain Metastases From a Lung Adenocarcinoma With a Sensitizing EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Can We Omit Radiotherapy in Case of Brain Metastases for Patients With Mutant EGFR Lung Adenocarcinoma?
Translational Lung Cancer Research
Oncology